glycosylated chicken growth hormone

7
GENERAL AND COMPARATIVE ENDOCRINOLOGY 68, 408-414 (1987) Glycosylated Chicken Growth Hormone Luc R. BERGHMAN,*,' P LENS,* E. DECUYPERE,~,~E. R. K~~HN,$AND F. VANDESANDE* “Laboratory for Neuroendocrinology and Immunological Biotechnology, Naamsestraat 59, B 3000 Louvain; fLaboratory for Physiology of Domestic Animals, Kardinaal Mercierlaan 52, B 3030 Louvain; and $Laboratory for Comparative Endocrinology, Naamsestraat 61, B 3000 Louvain, Belgium Accepted July 17, 1987 In an attempt to raise monoclonal antibodies to chicken pituitary glycoprotein hormones, mice were immunized with the concanavalin A-adsorbed components of a hypophyseal extract. Fusions of these spleen cells with myeloma cells repeatedly yielded hybridoma lines secreting antibodies that recognized specifically the pituitary caudal acidophils, known as the somatotropes. This paper reveals the existence of a glycosylated counterpart of the well-established holoprotein form of chicken growth hormone, similar to what has been established for human growth hormone and prolactin. o 1987 Academic press, IDC. The electrophoretic heterogeneity of pu- rified GH preparations is a well-established feature (Cheever and Lewis, 1969). The formation of oligomers on the one hand and the occurrence of purification and/or anal- ysis artifacts on the other hand have been -among others-fairly satisfactory expla- nations to date (Lewis et al., 1980; Stolar and Baumann, 1986). Recently, the discovery of a glycosylated human GH form (G HGH) (Sinha and Lewis, 1986) provided an alternative view on this matter. Very similar modifications of ovine prolactin and human prolactin had been reported earlier (Lewis et al., 1985). Glycosylation of a holoprotein caused an increase of the molecular weight in each of these cases. This led to our search for a pu- tative glycosylated counterpart of the well- known holoprotein form of chicken growth hormone. MATERIALS AND METHODS Fractionation of the crude hypophyseal extract. Chicken pituitaries were collected from broiler heads obtained from a processing company and fractionated by a method derived from the protocol of Burke and Papkoff (1980). In brief, pituitaries were homogenized i Supported by the Belgian Nationaal Fonds voor Wetenschappebjk Onderzoek. with an Ultraturrax mixer in ice-cold water (20 ml/g tissue). Phenylmethylsulfonyl fluoride (Sigma), solubi- lized in a small amount of acetone, was added at a 1 mM concentration (Gold, 1967). The pH was adjusted to 9.5 with a saturated calcium hydroxide solution and extraction was performed at 4” for 3 to 4 hr under con- stant magnetic stirring. After centrifugation, the supematant was brought to pH 4 with metaphosphoric acid and to 0.15 M am- monium sulfate, yielding a first precipitate known to contain GH and prolactin (PRL) (Licht et al., 1977). The remaining supernatant was adjusted to pH 6.5 and 0.8 saturation ammonium sulfate. After overnight stir- ring, the precipitate, containing the glycoproteins, was harvested by centrifugation. Con A affinity chromatography. A 30-ml (2.6 X S-cm) column of concanavalin A (Con A)-Sepharose 4B (Pharmacia) was equilibrated with 20 mM Tris- HCl buffer containing 0.15 M NaCl, 1 mM MnCl,, and 1 mM CaCl, (Ui et al., 1977). The 0.15 M-O.8 satura- tion ammonium sulfate precipitate was solubilized in the same buffer and desalted by gel permeation chro- matography on a PD 10 column (Sephadex G-25 M, Pharmacia) equilibrated with the same buffer and then loaded on the Con A column. After the column was washed to baseline absorption (280 nm) with 5 bed volumes of buffer, the adsorbed glycoproteins were eluted by addition of 0.5 M a-methylglucoside to the starting buffer. The preparation was concentrated by ultrafiltration through an Amicon YM5 membrane. Preparation of monoclonal antibodies. Six-week- old BALB/C mice were injected four times subcutane- ously with a 50:50 complete Freund’s adjuvant:glyco- protein preparation emulsion, the immunogenic dose being the equivalent of 20 pituitaries. Three weeks after the last subcutaneous injection, an intraperi- 408 0016-6480/87 $1.50 Copyright 0 1987 by Academic Press, Inc. All rights of reproduction in any form reserved.

Upload: tamu

Post on 04-Nov-2023

0 views

Category:

Documents


0 download

TRANSCRIPT

GENERAL AND COMPARATIVE ENDOCRINOLOGY 68, 408-414 (1987)

Glycosylated Chicken Growth Hormone

Luc R. BERGHMAN,*,' P LENS,* E. DECUYPERE,~,~E. R. K~~HN,$AND F. VANDESANDE*

“Laboratory for Neuroendocrinology and Immunological Biotechnology, Naamsestraat 59, B 3000 Louvain;

fLaboratory for Physiology of Domestic Animals, Kardinaal Mercierlaan 52, B 3030 Louvain; and $Laboratory for Comparative Endocrinology, Naamsestraat 61, B 3000 Louvain, Belgium

Accepted July 17, 1987

In an attempt to raise monoclonal antibodies to chicken pituitary glycoprotein hormones, mice were immunized with the concanavalin A-adsorbed components of a hypophyseal extract. Fusions of these spleen cells with myeloma cells repeatedly yielded hybridoma lines secreting antibodies that recognized specifically the pituitary caudal acidophils, known as the somatotropes. This paper reveals the existence of a glycosylated counterpart of the well-established holoprotein form of chicken growth hormone, similar to what has been established for human growth hormone and prolactin. o 1987 Academic press, IDC.

The electrophoretic heterogeneity of pu- rified GH preparations is a well-established feature (Cheever and Lewis, 1969). The formation of oligomers on the one hand and the occurrence of purification and/or anal- ysis artifacts on the other hand have been -among others-fairly satisfactory expla- nations to date (Lewis et al., 1980; Stolar and Baumann, 1986).

Recently, the discovery of a glycosylated human GH form (G HGH) (Sinha and Lewis, 1986) provided an alternative view on this matter. Very similar modifications of ovine prolactin and human prolactin had been reported earlier (Lewis et al., 1985). Glycosylation of a holoprotein caused an increase of the molecular weight in each of these cases. This led to our search for a pu- tative glycosylated counterpart of the well- known holoprotein form of chicken growth hormone.

MATERIALS AND METHODS Fractionation of the crude hypophyseal extract.

Chicken pituitaries were collected from broiler heads obtained from a processing company and fractionated by a method derived from the protocol of Burke and Papkoff (1980). In brief, pituitaries were homogenized

i Supported by the Belgian Nationaal Fonds voor Wetenschappebjk Onderzoek.

with an Ultraturrax mixer in ice-cold water (20 ml/g tissue). Phenylmethylsulfonyl fluoride (Sigma), solubi- lized in a small amount of acetone, was added at a 1 mM concentration (Gold, 1967). The pH was adjusted to 9.5 with a saturated calcium hydroxide solution and extraction was performed at 4” for 3 to 4 hr under con- stant magnetic stirring.

After centrifugation, the supematant was brought to pH 4 with metaphosphoric acid and to 0.15 M am- monium sulfate, yielding a first precipitate known to contain GH and prolactin (PRL) (Licht et al., 1977). The remaining supernatant was adjusted to pH 6.5 and 0.8 saturation ammonium sulfate. After overnight stir- ring, the precipitate, containing the glycoproteins, was harvested by centrifugation.

Con A affinity chromatography. A 30-ml (2.6 X

S-cm) column of concanavalin A (Con A)-Sepharose 4B (Pharmacia) was equilibrated with 20 mM Tris- HCl buffer containing 0.15 M NaCl, 1 mM MnCl,, and 1 mM CaCl, (Ui et al., 1977). The 0.15 M-O.8 satura- tion ammonium sulfate precipitate was solubilized in the same buffer and desalted by gel permeation chro- matography on a PD 10 column (Sephadex G-25 M, Pharmacia) equilibrated with the same buffer and then loaded on the Con A column. After the column was washed to baseline absorption (280 nm) with 5 bed volumes of buffer, the adsorbed glycoproteins were eluted by addition of 0.5 M a-methylglucoside to the starting buffer. The preparation was concentrated by ultrafiltration through an Amicon YM5 membrane.

Preparation of monoclonal antibodies. Six-week- old BALB/C mice were injected four times subcutane- ously with a 50:50 complete Freund’s adjuvant:glyco- protein preparation emulsion, the immunogenic dose being the equivalent of 20 pituitaries. Three weeks after the last subcutaneous injection, an intraperi-

408 0016-6480/87 $1.50 Copyright 0 1987 by Academic Press, Inc. All rights of reproduction in any form reserved.

GLYCOSYLATED CHICKEN GROWTH HORMONE 409

toneal booster with the same dose of immunogen solu- bilized in 200 pl of saline was administered.

Three days later, a suspension of spleen cells was prepared and fused with NP3 myeloma cells (Flow Laboratories), by addition of 50% polyethylene glycol solution, according to the protocol provided by GIBCO BRL in the HyBRL prep kit. The fusion mix- ture was routinely dispersed into four 96-well plates with 3 x 105 thymocytes and hybridoma growth factor (Janssen Pharmaceutics) (Aarden et al., 1985) as the growth-promoting conditions.

Screening was performed immunocytochemically 10 and 17 days after fusion. A home-developed device for the suitable and accurate processing of numerous cul- ture supernatants was used (Berghman and Horsten, 1987).

Among others, the fusate wells containing the GH- like immunoreactive antibodies were expanded, frozen, and cloned by limiting dilution to yield exclu- sively monoclonal cultures. Ascites fluid was pro- duced in adult male BALB/C mice that were primed with a 0.5-ml pristane (Janssen Pharmaceutics) injec- tion 10 days before the inoculation with 5 x lo6 hy- bridoma cells in 0.5 ml serum-free medium.

Electrophoresis and immunoblotting. Chemical analysis of the precipitates was performed by sodium dodecyl sulfide (SDS)-polyacrylamide gradient (8-16%) gel electrophoresis (PAGE). Proteins in the gels were transferred to nitrocellulose sheets by semi- dry electroblotting (Kyhse-Anderson, 1985). Immuno- detection was carried out with rabbit anti-ovine GH antisera (l/1000) as a reference. For the detection of the primary antibody an alkaline phosphatase-conju- gated second antibody (Dakopatts, dilution l/400) and nitroblue tetrazolium-5-bromo-4-chloro-3-indolyl phosphate (NBT-BCIP) as chromogenic substrate (Promega) were used (Blake et a/., 1984). Total protein staining was done with Coomassie brilliant blue (Serva, Blau R Nr 35051) and silver staining methods.

To exclude the risk of aspecific adsorption of non- glycosylated components to the Sepharose matrix of the Con A column, an in situ localization of glycopro- tein$ on nitrocellulose, based on binding of solubilized lectin, was developed.

Blotting of the glycoprotein-containing gel strips was performed following a routine protocol. The non- occupied protein sites were blocked by a 60-min im- mersion in a 5% bovine serum albumin-Tris-HCl buffer @H 7) solution. After a washing cycle with Con A buffer (Tris-HCl, pH 7, t 1 mM CaCl, + 1 m&4 MI&$) the nitrocellulose strip was incubated in a so- lution of 4 p.g Con A/ml Con A buffer for 30 mm. Sta- bilization of the glycoprotein-lectin complex-neces- sitated by the strongly alkaline and therefore desta- bilizing immunodetection substrate solution-was achieved by oxidation of the c,arbohydrate moiety of the glycoprotein into aldehyde functions. These active groups were allowed to react with primary amino

functions of the closely associated lectin molecule. The oxidation was carried out with a 10 m?r4 IO,- so- lution in phosphate buffer (PH 7) for 15 min. The ex- cess active groups after the crosslinking were blocked with a 100 m&4 glycine, pH 7, solution for 1.5 min. Im- munodetection of the bound Con A was carried out with rabbit anti-Con A antiserum (l/5000, Dakopatts), swine anti-rabbit IgG-alkaline phosphatase conjugate (11400, Dakopatts), and NBT-BCIP as substrate system.

Potential glycosylated contaminants of the commer- cial serum albumin source (Sigma fraction V) that was used during the quenching step were batchwise ad- sorbed to Con A-Sepharose, prior to its use. The presence of such glycosylated albumin derivatives can be ex,plained by nonenzymatic. glycosylation ‘of al- bumin (Rendell et al., 1986). This purification step has proved to be necessary for background reduction (Glass et al., 1981).

As a control for the method specificity, 1 mg cv- methylglucosideiml was added to the Con A solution. This excess sugar had to be able to block the binding of Con A to solid-phase glycoprotein. If no. aspecific interaction of detection reagents was present, the staining result had to be negative in this instance- which is what actually happened.

One-step isolation of electrophoretically pure gly- cosylated GH. Because the glycosylated GH compo- nents represent only a minor portion,of the total GH population, a quick and high-yield purification had to be designed. Therefore, a monoclonal antibody*based immunoadsorbent to GH was developed after puriflca- tion of the antibodies from high-titer ascitessfluid. Typically 5 mg of monoclonal anti-GH was coupled to CNBr-activated Sepharose 4B. Coupling efficieficy as determined by 280~nm absorption prior to and after coupling usually exceeded 95%.

The final chromatographic purification schedule im- plied the connection of the immunoaffinity column to the outlet of the Con A-Sepharose column during its elution step with ol-methylglucoside. This prevented sample and time loss in manipulation and dialysis of the eluate of the lectin column. Consecutive elutlon of the immunoadsbrbent with a glycine-Hd buffer (pH 2.6) yielded the pure glycosylated forms of OH.

RESULTS

After the alkaline extraction of chicken pituitary tissue, addition of 0.15 M am- monium sulfate and metaphosphoric acid to pH 4 yielded the precipitation of a com- plex protein mixture (Fig. 1, IB). One of the predominant components of this mix- ture was identified as the growth hormone band using rabbit anti-ovine GH (NIH) an-

410 BERGHMAN ET AL.

A 0 C A B

FIG. 1. Part I: 816% SDS-polyacrylamide gradient gel, stained for total protein with Coomassie brilliant blue. (A) Low-molecular-weight standard proteins. Ribonuclease A (13,000 Da), chymotryp- sinogen A (25,000 Da), ovalbumin (43,000 Da), and bovine serum albumin (67,000 Da). (B) Ammonium sulfate precipitate (O-O.15 M), solubilized in 10% SDS prior to electrophoresis. The arrow indicates the position of the GH band. (C) Affinity-purified chicken GH. (D) Con A-adsorbed fraction of the 0.15 M-0.8 saturation ammonium sulfate precipitate. The glycosylated GH forms are indicated with arrows. (E) The affinity-purified glycosylated GH forms. During the elution step of the Con A affinity column, the glycosylated GH forms are loaded on the anti-GH affinity column and eluted with a low pH buffer after the routine washing steps. One of the forms has molecular weight that is very close to that of the holoprotein. The larger form has an apparent molecular mass of 25,000 Da. Part II: Immu- noblotting results after semidry blotting of various electrophoretograms. (A) Detection of the holo- protein form in the O-O.15 M ammonium sulfate precipitate with rabbit anti-ovine GH antisera. The use of a mouse anti-chicken GH monoclonal antibody for the detection gives the same result. (B) The glycosylated forms of chicken GH detected among the Con A-adsorbed material with the same anti- sera. Part III: In situ glycoprotein detection on a blot of purified glycosylated chicken GH. Only the major form is detectable. The minor form might be present in nondetectable amounts or more prob- ablv contains very little sugar residues. This could explain the negligible difference in molecular weight with the protein band of GH.

tisera on nitrocellulose blots of an S-16% SDS-PAGE electrophoretogram (Fig. 1, IIA). The validation of the heterologous antiserum for this purpose was performed on chicken pituitary sections, where the somatotropes are easily recognized as the caudal acidophils (Tixier-Vidal and Follett, 1973; Mikami, 1983). No detectable cross- reactions with other cell types were noticed (Fig. 2). The isolation and identification of this growth hormone-like immunoreactive band as growth hormone-both biologi- cally and biochemically (including partial amino acid sequence determination)- have already been performed in our labora- tories and will be reported elsewhere.

Addition of ammonium sulfate to 0.8 sat- uration and pH adjustment to 6.5 caused

the precipitation of virtually all the protein that was left into solution after the first pre- cipitation step. Purification of this precipi- tate over Con A-Sepharose reveals that the majority of the second ammonium sul- fate precipitate passes unadsorbed through the column, whereas only about 10% was bound to the lectin and eluted afterward by addition of 0.5 M a-methylglucoside (Fig. 3).

SDS-PAGE (S-16%) of this fraction shows three major components. One of these (around 15,000 Da) presumably cor- responds to, the subunits of the gonado- tropins and thyrotropin. The two other bands (22,000 and 25,000 Da) are identified immunologically as GH immunoreactive components (Fig. 1, IIB) using the rabbit

GLYCOSYLATED CHICKEN GROWTH HORMONE 411

FIG. 2. Immunocytochemical demonstration of the somatotropes in the caudal lobe of the chicken adenohypophysis, using a rabbit anti-ovine GH antiserum in a l/1000 dilution. Goat anti-rabbit IgG (l/20), PAP complex, and diaminobenzidinehydrochloride-H,Oz were used as detection system.

anti-ovine GH antisera on nitrocellulose The presence of GH immunoreactive blots of the electrophoretogram. The larger glycosylated components in the Con A-ad- component of both obviously has a signifi- sorbed fraction was demonstrated again cantly higher molecular weight than the when monoclonal antibodies were raised GH band in the first protein precipitate. using the glycosylated portion of the The glycosylated nature of these compo- second ammonium sulfate precipitate as nents was confirmed by their in situ lectin- antigenic mixture. The resulting hybridoma binding capacity (Fig. I, III).

1 .o

0.2

0

! A230 UFS

0.1

-

0.02

10 60

.2 A2a 0”

!

lines were divided into four immunocyto-

‘60 300 400 ml-

loading washing eiution

FIG. 3. Elution profne of a routine Con A affinity chromatographic purification of the second am- monium sulfate precipitate. About 90% of the loaded material passes through the column with the void volume. Only a minor portion (around 10%) is adsorbed specifically and eluted by the addition of05 ol-methylglucoside to the starting buffer.

412 BERGHMAN ET AL.

chemical specificity groups. One group of cell lines produced antibodies that recog- nized a cephalic cell population that was identified as the ACTH cells using a heter- ologous rabbit anti-human ACTH anti- serum as a reference. One other group ret- ognized specifically the castration cells in the chicken pituitary and the third group recognized both castration and thyroidec- tomy cells. But the two different fusion ex- periments also produced 12 immunocyto- chemically growth hormone cell-positive hybridoma lines. These antibodies were able to recognize not only the glycosylated GH forms that were part of the antigenic mixture, but also the classic GH band from the first precipitate as is shown by the im- munoblotting results. These antibodies have been used to develop an anti-GH im- munoadsorbent to allow a simple and effi- cient purification of the proteins we de- scribed. It was sufficient indeed to load the glycoprotein fraction on the GH immunoaf- finity column as it was desorbed from the lectin affinity column. No interference of the added glucoside with the immunologic binding of the components was noticed. Elution of the immunoaffinity column pro- duced a pure preparation of two glyco- sylated GH forms (Fig. 1, IE).

DISCUSSION

As expected from previous reports (Leung et al., 1984) most of the chicken GH precipitated at pH 4 and 0.15 M am- monium sulfate, along with a vast variety of other proteins (Fig. 1, IB and IC).

On the other hand, a dozen GH cell- staining cell lines emerged along with some 30 others during the production of mono- clonals toward exclusively lectin-bound material. The accuracy of the affinity chro- matographic procedure-already men- tioned in a number of other reports (Kuhn et al., 1986; Ui et al., 1977; Idler and Hwang, 1978)-was clearly proved for the GH-immunoreactive component of the gly- coprotein mixture. Its binding to the

column was the result of specific interac- tion with the ligand (i.e., the lectin con- canavalin A) and had nothing to do with adsorption to the inert matrix (Fig. 1, III). It also predicts the presence of glycosyl and/or mannosyl residues within the carbo- hydrate portion of the described molecule, but more detailed investigation will be nec- essary to learn more about its exact com- position. The cell lines we mentioned above thus clearly prove the existence of a glycosylated GH cell-specific component within the immunogenic mixture. The physicochemical nature of this component could be-at least partially-elucidated by means of electrophoresis and immunoblot- ting.

These techniques revealed indeed the presence of two glycosylated minor com- ponents on top of the major, faster mi- grating GH band in the holoprotein precipi- tate. The growth hormone-like nature of these products, suggested by their similar molecular size, was confirmed by their im- munopositive reaction with the rabbit anti- ovine GH antiserum. This antiserum had already been showing an exclusive immu- nocytochemical specificity for the somato- tropic cell population of the chicken pars distalis.

In addition to this, all the monoclonal an- tibodies to the glycosylated GH were able to recognize the nonglycosylated counter- part, pleading for strong immunologic re- semblance between both. Moreover, the same immunoadsorbent used in combina- tion with the Con A matrix that was used in these experiments to purify glycosylated growth hormone was used afterward to iso- late a complete growth hormone prepara- tion (i.e., containing glycosylated and nonglycosylated components) from a total pituitary extract. Amino acid sequencing confirmed its predicted identity and re- vealed no heterogeneity for the amino ter- minus of the molecule (data to be pub- lished).

Apart from these immunochemical and

GLYCOSYLATED CHICKEN GROWTH HORMONE 413

physicochemical similarities, preliminary physiological experiments have also clearly shown that the hormonal activity must be considered at least comparable to that of the nonglycosylated counterpart (data to be published). Pankov and Butnev (1986) re- ported the same feature for porcine pro- lactin.

The absence of glycosylated form-spe- cific monoclonals in the fusion results is explained by its very restricted portion of the total amount of GH present in the chicken pituitary. If any antibodies of this specificity were produced, the staining re- sponse in the screening protocol must have been almost negligible, due to an insuffi- cient amount of antigen present.

These results strongly suggest the exis- tence of a glycosylated GH in the chicken pituitary. The similarity to the phenomena described for human GH, human PRL, and ovine PRL is striking (Lewis et al., 1984, 1985; Sinha et al. 1984; Sinha and Lewis, 1986).

Unfortunately, the molecular back- grounds for nonmammalian hormones are not sufficiently known to allow a thorough comparison with, e.g., human GH. The demonstration of a homologous Asn-X-Ser (Thr) sequence, necessary for N-glycosyla- tion (Bahl and Shah, 1977), would greatly elucidate the situation. This might now be- come feasible with the affinity purification protocol described in this paper that allows one to purify a respectable amount of pure material even from a rather poor source.

On the other hand it would be most inter- esting to know whether the glycosylated GH form is not only synthetized in the pitu- itary but also secreted into the circulation, as is the case for human prolactin (Sinha et al., 1984). The particular importance of this aspect comes from the knowledge that gly- cosylation of a secretory protein is an im- portant factor for the reduction of its clear- ance from the circulation and thus for the enhancement of its biological activity at the same time (Pankov and Butnev, 1986).

ACKNOWLEDGMENTS

We thank the NIH for the gift of ovine growth hor- mone and Dr. Balthazart (Liege, Belgium) for the chicken pituitaries we were allowed to use. Mrs. J. Puttemans is gratefully acknowledged for her assis- tance in layout and photography.

REFERENCES

Aarden, L., Lansdorp, P., and De Groot, E. (1985). A growth factor for B cell hybridomas produced by human monocytes. Lymfokines 10, 175-185.

Bahl, 0. P., and Shah, R. H. (1977). In “The Glyco- conjugates” (M. I. Horowitz and W. Pigman, Eds.), Vol. 1, pp. 385-422. Academic Press, New York.

Berghman, L. Ii., and Horsten, G. (1987). Develop- ment of an interface between classical immunocy- tochemistry on regular glass slides and modern ELISA hardware for use in hybridoma screening technique, submitted for publication.

Berghman, L., Kuhn, E., and Vandesande, I? (1987). Purification of chicken pituitary growth hormone using monoolonal antibody based immunoadsor- bent and HPLC chromatography, submitted for publication.

Blake, M. S., Johnston, K. H., Russell-Jones, 6. J., and Gotschlich, E. C. (1984). A rapid, sensitive method far detection of alkaline-phosphatase- conjugated anti-antibody on western blots. Ancal. Biochem. 136, 175-179.

Burke, W. H., and Papkoff, H. (1980). Purification of turkey prolactin and the development of a homol- ogous radioimmunoassay for its measurement. Gen. Camp. Endocrinol. 40,297-307.

Cheever, E. V., and Lewis, U. J. (1969). Estimation of the molecular weights of the multiple components of growth harmone and prolactin. Endocrinology 85, 465-473.

Farmer, S. W., Papkoff, H., and Hayashida, T. (1974). Purification and properties of aviau growth hor- mone. Endocrinology 95, 1560-1565.

Glass, W. F., Briggs, R. C., and Hnilica, L. S. (1981). Use of lectirrs for the detection of electrophareti- tally separated glycoproteins transfeerred onto ni- trocellulose sheets. Anal. Biochem. 115, 219-224.

Gold, A. M. (1967). Sulfonation with sulfonyl halide~s. In “Methods in Enzymology (Hirs, C. H. W., Ed.), Vol. 11, pp. 706-711. Academic Press, New York.

Harvey, S., and Scanes, C. (1977). Purification and ra- dioimmunoassay of chicken growth hormone. J. Endocrinol. 73, 321-329.

414 BERGHMAN ET AL.

Idler, D. R., and Hwang, S. J. (1978). Conditions for optimizing recovery of salmon gonadotropin ac- tivity from Con A Sepharose. Gen. Camp. Endo-

crinol. 36, 642-644. Kiihn, E. R., Huybrechts, L., Govaerts, F., Ver-

beeck, E., and Ollevier, E (1986). The thyroxine- simulating activity is only present in the glyco- protein and not in the protein fraction of a carp hypophyseal homogenate. Gen. Comp. Endo-

crinol. 63, 321-327. Kyhse-Andersen, J. (1985). Electroblotting of multiple

gels: A simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J. Biochem. Biophys. Methods 10, 203 -209.

Leung, F. C., Taylor, J. E., Steelman, S. L., et al. (1984). Purification and properties of chicken growth hormone and the development of a homol- ogous radioimmunoassay. Gen. Comp. Endo- crinol. 56, 389-400.

Lewis, U. J., Singh, R., Lewis, L. J., Seavy, B. K., and Sinha, Y. (1984). Glycosylated ovine pro- lactin. Proc. Natl. Acad. Sci. USA 81, 385-389.

Lewis, U. J., Singh, R., Sinha, Y. N., and Vander- laan, W. (1985). Glycosylated human prolactin. Endocrinology 116, 359-363.

Lewis, U. J., Singh, R. N. P., Tutwiler, G. F., Sigel, M. B., Vanderlaan, E. F., and Vanderlaan, W. P. (1980). Human growth hormone: A complex of proteins. Recent Prog. Norm. Res. 36,477-508.

Licht, P., Papkoff, H., Muller, C. H., Tsui, H. W., and Crews, D. (1977). Evolution in gonadotropin structure and function. Recent Prog. Horm. Res. 33, 169-248.

Mikami, S. (1983). Avian adenohypophysis: Recent progress in immunocytochemical studies. In “Avian Endocrinology: Environmental and Eco- logical Perspectives (S. Mikami ef al., Eds.), pp. 39-56. Springer-Verlag, Berlin/New York.

Nicoll, C. S., and Licht, P. (1971). Evolutionary bi- ology of prolactins and somatotropins: II. Elec- trophoretic comparison of tetrapod somato- tropins. Gen. Comp. Endocrinol. 17, 409-507.

Pankov, Y. A., and Butnev, V. Y. (1986). Multiple forms of pituitary prolactin, a glycosylated form of porcine prolactin with enhanced biological ac- tivity. Znt. J. Pept. Res. 28, 113-123.

Rendell, M., Rasbold, K., et al. (1986). Comparison and contrast of affinity chromatographic determi- nations of plasma glycated albumin and total gly- cated plasma protein. Clin Biochem. 19, 216-220.

Scanes, C. G., and Harvey, S. (1981). Growth hor- mone and prolactin in avian species. Life Sci. 28,

2895-2902.

Sinha, Y. N., Gilligan, T. A., and Lee, D. W. (1984). Detection of a high molecular weight variant of prolactin in human plasma by a combination of electrophoretic and immunologic techniques. J.

Clin. Endocrinol. Metab. S(4), 752-754.

Sinha, Y. N., and Lewis, U. J. (1986). A lectin-binding immunoassay indicates a possible glycosylated growth hormone in the human pituitary gland. Biochem. Biophys. Res. Commun. 140(2), 491-497.

Stolar, M. W., and Baumann, G. (1986). Big growth hormone forms in human plasma: Immunochem- ical evidence for their pituitary origin. Metabo-

lism 35(l), 75-77.

Tixier-Vidal, A., and Follett, B. (1973). The adenohy- physis. In “Avian Biology” (D. S. Farner and J. R. King, Eds.), Vol. 3, pp. 109-182. Academic Press, New York.

Ui, N., Tamura-Takahashi, H., Yora, T., and Cond- liffe, P. G. (1977). Bio-affinity chromatography of thyrotropin using immobilized Concanavalin A. Biochim. Biophys. Acta 497, 812-815.